CClinicalTrials.gg
Not yet recruitingNCT07008482Updated Aug 12, 2025

Effects of Music on Preoperative Anxiety in Patients With Femoral Fractures Undergoing Surgery

An interventional study of Music intervention in Anxiety, Pain and Surgery, sponsored by Azienda Unita Sanitaria Locale di Piacenza. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-12.

Sponsored by Azienda Unita Sanitaria Locale di Piacenza · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
154
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This randomized controlled trial (RCT) investigates the effectiveness of music therapy in reducing preoperative anxiety among elderly patients with femoral fractures. Preoperative anxiety is known to worsen physiological stability, increase pain perception, and negatively impact recovery, yet specific evidence on non-pharmacological interventions like music therapy in the orthogeriatric setting is lacking.

The study will enroll 154 adult patients admitted to the Orthogeriatrics Unit for elective femoral fracture surgery. Participants will be randomly assigned to receive either a 20-minute session of music therapy or standard care. Anxiety will be measured using the APAIS scale, and pain will be assessed with the NRS scale, both before and after the intervention.

The trial is designed as a blinded, prospective RCT, with data collected and managed under current privacy regulations. By generating robust data on this low-cost, safe intervention, the study aims to improve preoperative management and patient outcomes in orthopedic surgical care.

02

Conditions studied

  • Anxiety
  • Pain
  • Surgery
  • Femoral Fractures
  • Music Therapy

Keywords

  • NURSING
  • MUSICTHERAPY
  • ANXIETY
  • PAIN
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients of both sexes, 18 years of age or older
  • Patients with femur fracture who are candidates for surgery
  • Able to provide informed consent.

Exclusion criteria

Exclusion Criteria:

  • Patients with a diagnosis of hearing loss
  • Patients diagnosed with cognitive or psychiatric disorders
  • Patients undergoing emergency/emergency surgery
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
154 participants (estimated)

Study arms

  • Experimental
    MUSIC THERAPY

    Other: Music intervention

  • No intervention
    NO MUSICTHERAPY

Interventions

  • OtherMusic intervention

    patient enrolment, administration of the APAIS and NRS scales (T0), administration of the standard music therapy/assistance intervention (20 minutes duration), re-evaluation with re-administration of the APAIS and NRS scales (T1) and completion of the CRF. The administration will take place at the patient's bedside, respecting the privacy and confidentiality of the subjects involved, guaranteeing absolute tranquillity, also with the help of dividers to avoid distractions and interruptions.

05

What researchers measure

Primary outcomes

  1. Difference between the Amsterdam Preoperative Anxiety and Information Scale (APAIS) at T0 and T1

    Difference in preoperative anxiety level after 20 minutes and baseline evaluated by APAIS scores between T0 and T1. The APAIS consists of six questions, with each question rated on a 5-point Likert scale (1=not at all, 5=extremely), and has a minimum score of 6 and a maximum score of 30. Higher APAIS scores indicate a worse outcome with higher levels of anxiety and a greater desire for information.

    Time frame: Baseline and 20 minutes after baseline

06

Study locations

No study locations are listed for this record.

07

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07008482
Lead sponsor
Azienda Unita Sanitaria Locale di Piacenza
Responsible party
Massimo Guasconi (RN, MSN, Azienda Unita Sanitaria Locale di Piacenza) — Principal investigator
First posted
Jun 6, 2025
Start date
Sep 2025 (estimated)
Primary completion
Jul 2026 (estimated)
Completion
Jul 2026 (estimated)
Last update
Aug 12, 2025

Study contacts

Massimo Guasconi, MSN
Contact
m.guasconi2@ausl.pc.it
+390523303854

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion